Skip To Content

ACD/Labs Blog

Sherry Myles
Efficiency in R&D helps us be more productive, optimize, and innovate. Our recent virtual symposium “Driving Efficiency with Spectrus” brought together scientists from industry-leading organizations (like GSK, AstraZeneca, Genentech, and more) to share strategies that they have implemented, to: Accelerate structure elucidation and verification by NMR and LC/MS Make method development efficient, robust, and sustainable...

Daria Thorp
President and CEO, Daria Thorp, reflects on the past year and how the emerging technology of Generative AI and Machine Learning (ML) application in drug discovery and development has inspired companies to look for further industrial applications.

Sherry Myles
To support ongoing digital transformation in life sciences and chemistry-driven organizations, ACD/Labs has introduced Spectrus Conduit—the first out-of-the-box, low-code/no-code application that connects, designs, and manages automated dataflows from analytical instruments and other data sources. Spectrus Conduit creates standardized, harmonized digital twins of the R&D laboratory, improves collaboration, and supports downstream AI/ML applications. ACD/Labs also announced...

Sherry Myles
Scientists and IT at AstraZeneca combined their expertise and knowledge to centralize analytical data management in a cloud-based solution and make immediately re-usable data available throughout discovery, development, and for machine learning applications. Read how their automated system—integrated with analytical instruments, their ELN, and archive—is delivering real benefits.

Sherry Myles
This release expands structure characterization functionality for scientists, improves analytical data management and assembly across analytical techniques and data formats, and further supports proliferation of data from the Spectrus platform to third party data science applications. Toronto, CANADA (September 12, 2023)—ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced...

Sherry Myles
The release expands format agnostic capabilities and provides dedicated tools to help scientists make faster decisions with assembled multi-technique analytical data, and delivers new functionality for NMR spectroscopists and mass spectrometrists. Toronto, CANADA (November 22, 2022)—ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced the release of version 2022...

Sherry Myles
Sanofi partnered with ACD/Labs to develop an automated lab tool combining LC/MS and 1H NMR to help organic chemists efficiently verify their structures. This tool collects, compiles, and evaluates the analytical data and the proposed structure once they are available, and sends the results to the chemist. The pilot project for this system is presented...

TetraScience
ACD/Labs is partnering with TetraScience, the Scientific Data Cloud company, to help pharmaceutical companies increase scientific data effectiveness. We invited Simon Meffan-Main, Ph.D., and Alan Millar, Ph.D., Vice Presidents, Tetra Partner Network, TetraScience, to share some insights on cloud computing in the pharmaceutical industry.